Knowing stock market today at a glance

Select Medical Stock Soars 13.86% on Earnings Report

Mover TrackerTuesday, Apr 8, 2025 6:03 am ET

1min read

On April 8, 2025, Select Medical's stock surged by 13.86% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Select Medical recently reported its Q4 earnings, which fell short of analysts' estimates, leading to a 7.2% drop in its stock price. The company projected revenues to be between $5.4 billion and $5.6 billion, indicating a cautious outlook for the coming quarters.

In another development, ubs group revised its price target for select medical, lowering it from $40.00 to $21.00 and maintaining a "neutral" rating on the stock. This adjustment reflects the market's concerns over the company's financial performance and future prospects.

Despite beating Q2 earnings estimates, Select Medical's stock experienced a 16.9% decline. The company expects its adjusted EBITDA to fall between $845 million and $885 million, highlighting the challenges it faces in maintaining profitability.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.